{"filing":{"accession_number":"0001378325-26-000045","cik":"0001378325","ticker":"CV","company_name":"CapsoVision, Inc","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-25","primary_document":"cv-20260925.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000045/cv-20260925.htm"},"events":[{"id":35387,"run_id":32591,"accession_number":"0001378325-26-000045","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"CapsoVision announced FDA clearance of AI Highlights™, an AI-assisted reading feature for its CapsoCam Plus® system, received on September 25, 2026. This is a material regulatory milestone for a commercial-stage medical technology company—FDA clearance of a new product feature expands the company's commercial capabilities and competitive positioning in the capsule endoscopy market. While not a specific named event type, this is clearly an operational/strategic milestone (regulatory approval enabling product commercialization) rather than a financial, governance, or legal event, making operational_other the most appropriate classification.","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39421,"accession_number":"0001378325-26-000045","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"CapsoVision announced FDA clearance of AI Highlights™, an AI-assisted reading feature for its CapsoCam Plus® system, received on September 25, 2026. This is a material regulatory milestone for a commercial-stage medical technology company—FDA clearance of a new product feature expands the company's commercial capabilities and competitive positioning in the capsule endoscopy market. While not a specific named event type, this is clearly an operational/strategic milestone (regulatory approval enabling product commercialization) rather than a financial, governance, or legal event, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T15:05:43.661590+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39421,"accession_number":"0001378325-26-000045","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"CapsoVision announced FDA clearance of AI Highlights™, an AI-assisted reading feature for its CapsoCam Plus® system, received on September 25, 2026. This is a material regulatory milestone for a commercial-stage medical technology company—FDA clearance of a new product feature expands the company's commercial capabilities and competitive positioning in the capsule endoscopy market. While not a specific named event type, this is clearly an operational/strategic milestone (regulatory approval enabling product commercialization) rather than a financial, governance, or legal event, making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T15:05:43.661590+00:00","company_name":"CapsoVision, Inc","ticker":"CV","filing_date":"2026-09-28"}]}